GLUMON:Next generation in-blood glucose monitoring using non-invasive optoacoustic sensing

GLUMON旨在利用在FET项目RSENSE （GA #862811）下开发的光声检测技术的进展，提供下一代体内定量非侵入性生化传感，其技术解决了现有生物医学传感器的局限性。一项推动创新是能够以便携式方式提供准确的葡萄糖测量，这将以完全无创的方式为透皮传感器提供卓越的性能，即不需要穿透皮肤屏障。GLUMON项目的目标是：-成熟的光声技术，从实验室台式装置到功能便携式传感器原型；-提高市场准备水平；-在实验室以及临床前和临床环境中验证和演示传感器；-制定合理的商业案例和开发策略；并解决该医疗器械的监管和道德要求，为下一阶段做准备。

GLUMON aims to leverage progress in optoacoustic detection, developed under the FET project RSENSE (GA #862811), to offer the next generation of quantitative non-invasive biochemical sensing in-vivo, with technology that addresses the limitations of existing biomedical sensors. A driving innovation is the ability to offer accurate glucose measurements in a portable way that would offer superior performance to transdermal sensors in a completely non-invasive fashion, i.e. without the need for penetrating the skin barrier.The objectives of the GLUMON project are to:-mature optoacoustic technology from a lab bench-top setup to a functional portable sensor prototype;-improve its market readiness level;-validate and demonstrate the sensor in the lab as well as in preclinical and clinical settings;-develop a sound business case and exploitation strategy; and-address regulatory and ethical requirements for this medical device in preparation for the next phase.